Top Markets
#1 Gravity Gravity +79.46%
#2 Galxe Galxe +41.81%
#3 Blast Blast +24.07%
#4 Velas Velas +23.00%
#5 Aria.AI Aria.AI +20.92%
#6 Derive Derive +17.73%
#7 Codatta Codatta +17.32%
#8 Fartcoin Fartcoin +14.63%
#9 Pepe Pepe +14.53%
#10 Wrapped QUIL Wrapped QUIL +14.35%
Coin of the day
Gravity Gravity
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Pfizer Inc. Pfizer Inc.

Pfizer Inc.

PFE
Kedudukan dalam Saham #115
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells... Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Harga Saham
$26.60
Modal Pasaran
$151.25B
Perubahan (1 hari)
-0.97%
Perubahan (1 tahun)
220.57%
Negara
US
Perdagangan Pfizer Inc. (PFE)

Kategori

Healthcare
Permodalan Pasaran
Pendapatan
lagi
Keuntungan
Sejarah Harga
Nisbah P/E
Nisbah P/S
Nisbah P/B
Margin Operasi
EPS
Pecahan Saham
Dividen
Hasil Dividen
Saham Terbitan
Nisbah P/E bagi Pfizer Inc. (PFE)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Pfizer Inc., nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi Pfizer Inc. dari 2026 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 42.86 -
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
 28.47 -
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 21.88 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 92.55 -
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 20.85 -
CH
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.